Prelude Therapeutics Incorporated Revenue and Competitors
Estimated Revenue & Valuation
- Prelude Therapeutics Incorporated's estimated annual revenue is currently $38.6M per year.
- Prelude Therapeutics Incorporated's estimated revenue per employee is $193,750
- Prelude Therapeutics Incorporated's total funding is $122M.
Employee Data
- Prelude Therapeutics Incorporated has 199 Employees.
- Prelude Therapeutics Incorporated grew their employee count by 9% last year.
Prelude Therapeutics Incorporated's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Legal Officer | Reveal Email/Phone |
3 | Executive Assistant to President and CMO | Reveal Email/Phone |
4 | Chief Business Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief People Officer | Reveal Email/Phone |
7 | President and Chief Medical Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | EVP & Head Chemistry | Reveal Email/Phone |
10 | VP and Head Process Chemistry, CMC | Reveal Email/Phone |
Prelude Therapeutics Incorporated Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $78.9M | 509 | 0% | N/A | N/A |
#2 | $1.1M | 7 | 17% | N/A | N/A |
#3 | $1.7M | 11 | -8% | N/A | N/A |
#4 | $1.4M | 9 | 0% | N/A | N/A |
#5 | $6.7M | 43 | 23% | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $10.5M | 68 | 24% | N/A | N/A |
#8 | $1.6M | 10 | 11% | N/A | N/A |
#9 | $1.4M | 9 | 29% | N/A | N/A |
#10 | $43.9M | 283 | 19% | N/A | N/A |
What Is Prelude Therapeutics Incorporated?
Prelude Therapeutics is a privately held biotechnology company focused on discovering and developing new medicines targeting chromatin function to treat cancer and rare diseases
keywords:N/A
$122M
Total Funding
199
Number of Employees
$38.6M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Prelude Therapeutics Incorporated News
2022-03-22 - Prelude Therapeutics Reports Full Year 2021 Financial Results
WILMINGTON, Del., March 16, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology...
2022-03-22 - Jane Huang, MD, Joins Prelude Therapeutics as President
WILMINGTON, Del., March 09, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) a clinical-stage precision oncology...
Other Companies in Wilmington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $60M | 202 | 3% | N/A |
#2 | $77.8M | 203 | 208% | N/A |
#3 | $26.9M | 204 | 13% | N/A |
#4 | $107.4M | 204 | 6% | $191M |
#5 | $48.3M | 209 | N/A | N/A |